Results 161 to 170 of about 12,032,280 (304)

Molecular replacement at its limits? The structure determination ofT. cruzig-glyceraldehyde-3-phosphate dehydrogenase, 12 monomers in the asymmetric unit and 41% data completeness at 3.5 Å resolution [PDF]

, 1996
B.G. Guimarães, Dulce Helena Ferreira de Souza, W D P Jesus, Glaucius Oliva   +3 more
openalex   +1 more source

Dual Role of Natural Killer Cells in Early Pregnancy: Immunopathological Implications and Therapeutic Potential in Recurrent Spontaneous Abortion and Recurrent Implantation Failure

Cell Proliferation, Volume 58, Issue 9, September 2025.
This article elaborates on the role of NK cells in early pregnancy from multiple perspectives, including molecular mechanisms and therapeutic interventions. It also discusses how NK cell dysfunction contributes to RSA and RIF, aiming to provide insights for future research on NK cell mechanisms and clinical treatment of RSA and RIF.
Defeng Guan, Zhou Chen, Yuhua Zhang, Wenjie Sun, Lifei Li, Xia Huang   +5 more
wiley   +1 more source

Impact of Laboratory-Adapted Intracellular Trypanosoma cruzi Strains on the Activity Profiles of Compounds with Anti-T. cruzi Activity. [PDF]

Microorganisms, 2023
Sykes ML, Kennedy EK, Avery VM.
europepmc   +1 more source

Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses. [PDF]

, 1998
Benjamin Wizel, Margarita Palmieri, Carmen de Mendoza, Byron Arana, John Sidney, Alessandro Sette, Rick L. Tarleton   +6 more
openalex   +1 more source

THE CULTIVATION OF TRYPANOSOMA CRUZI [PDF]

Journal of Bacteriology, 1951
Paul A. Little, J. J. Oleson
openaire   +3 more sources

Metabolic Profile Associated With Encystation in Acanthamoeba

Journal of Eukaryotic Microbiology, Volume 72, Issue 5, September/October 2025.
ABSTRACT The genus Acanthamoeba includes widespread protozoa that can cause severe infections in humans. Their ability to form resistant cysts within infected tissues complicates treatment, making it essential to understand the encystation process for developing effective therapeutic strategies.
Cecília Cirelli, Isabela Aurora Rodrigues, Jéssica Gardone Vitório, Filipe Fideles Duarte‐Andrade, Gisele André Baptista Canuto, Leiliane Coelho André, Juliano Simões de Toledo, Ana Paula Fernandes, Adriana Oliveira Costa   +8 more
wiley   +1 more source

Aplastic Anemia and Chagas Disease: T. cruzi Parasitemia Monitoring by Quantitative PCR and Preemptive Antiparasitic Therapy. [PDF]

Trop Med Infect Dis, 2022
Carvalho NB, de Freitas VT, Bezerra RC, Nakanishi ES, Velloso EP, Higashino HR, Batista MV, Fonseca GH, Rocha V, Costa SF, Shikanai-Yasuda MA.   +10 more
europepmc   +1 more source

How are antibodies involved in the protective mechanism of susceptible mice infected with T. cruzi? [PDF]

, 2000
Lilia F. Umekita, I. Mota
openalex   +1 more source

Evaluation of the Performance of Ortho T. cruzi ELISA Test System for the Detection of Antibodies to Trypanosoma cruzi. [PDF]

J Clin Microbiol, 2022
Rivera HN, McAuliffe I, Aderohunmu T, Wiegand RE, Montgomery SP, Bradbury RS, Handali S.   +6 more
europepmc   +1 more source

Review of Chagas Disease and Treatment Obstacles to Eradication [PDF]

, 2019
The World Health Organization and the Center for Disease Control reports Chagas disease, or American trypanosomiasis, as a major neglected tropical disease prevalent in 21 endemic Latin American countries.
Sherman, Emily
core   +1 more source